TNFR Pathway-Related Proteins and Recurrent Coronary Artery Disease Events

JACC Adv. 2026 Mar 19;5(4):102687. doi: 10.1016/j.jacadv.2026.102687. Online ahead of print.ABSTRACTBACKGROUND: Despite optimization with lifestyle modifications and medications, complications of coronary artery disease (CAD) remain the leading cause of adult mortality worldwide.OBJECTIVES: This stu

J Jiwoo Lee

Underweight and the Risk of Atrial Fibrillation in the Asian Population

Curr Med Chem. 2026 Mar 19. doi: 10.2174/0109298673374296251128092054. Online ahead of print.ABSTRACTINTRODUCTION: While previous studies suggest a higher incidence of atrial fibrillation (AF) among underweight individuals, this association remains underexplored in Asian populations. We aimed to sys

M Miao Zhang

Pharmacological and non-pharmacological management of long COVID

Virol J. 2026 Mar 21. doi: 10.1186/s12985-025-02991-5. Online ahead of print.ABSTRACTCoronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a major global health burden in terms of acute infection and long-term consequences. Approximat

K Kanwal Khalid

Remote monitoring of heart failure exacerbations using a smartwatch

Nat Med. 2026 Mar;32(3):924-933. doi: 10.1038/s41591-026-04247-3. Epub 2026 Mar 20.ABSTRACTHeart failure (HF) involves cycles of remission and exacerbation, which are poorly characterized by static disease measures. Consumer wearables have an understudied potential for daily monitoring of HF symptom

Y Yuan Gao